Christopher Peetz - Net Worth and Insider Trading
Christopher Peetz Net Worth
The estimated net worth of Christopher Peetz is at least $14 Million dollars as of 2024-11-28. Christopher Peetz is the CHIEF EXECUTIVE OFFICER of Mirum Pharmaceuticals Inc and owns about 305,682 shares of Mirum Pharmaceuticals Inc (MIRM) stock worth over $14 Million. Christopher Peetz is also the Director of Alpine Immune Sciences Inc and owns about 1,900 shares of Alpine Immune Sciences Inc (ALPN) stock worth over $123,443. Details can be seen in Christopher Peetz's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Peetz has not made any transactions after 2024-02-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher Peetz
Christopher Peetz Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher Peetz owns 3 companies in total, including Mirum Pharmaceuticals Inc (MIRM) , Alpine Immune Sciences Inc (ALPN) , and Regado Biosciences Inc (RGDO) .
Click here to see the complete history of Christopher Peetz’s form 4 insider trades.
Insider Ownership Summary of Christopher Peetz
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MIRM | Mirum Pharmaceuticals Inc | 2024-02-02 | director & President and CEO |
| ALPN | Alpine Immune Sciences Inc | 2021-09-23 | director |
| RGDO | Regado Biosciences Inc | 2016-11-01 | Chief Financial Officer |
Christopher Peetz Latest Holdings Summary
Christopher Peetz currently owns a total of 2 stocks. Among these stocks, Christopher Peetz owns 305,682 shares of Mirum Pharmaceuticals Inc (MIRM) as of February 2, 2024, with a value of $14 Million and a weighting of 99.14%. Christopher Peetz also owns 1,900 shares of Alpine Immune Sciences Inc (ALPN) as of September 23, 2021, with a value of $123,443 and a weighting of 0.86%.
Latest Holdings of Christopher Peetz
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MIRM | Mirum Pharmaceuticals Inc | 2024-02-02 | 305,682 | 46.65 | 14,260,065 |
| ALPN | Alpine Immune Sciences Inc | 2021-09-23 | 1,900 | 64.97 | 123,443 |
Holding Weightings of Christopher Peetz
Christopher Peetz Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher Peetz has made a total of 7 transactions in Mirum Pharmaceuticals Inc (MIRM) over the past 5 years, including 2 buys and 5 sells. The most-recent trade in Mirum Pharmaceuticals Inc is the sale of 6,013 shares on February 2, 2024, which brought Christopher Peetz around $157,480.
According to the SEC Form 4 filings, Christopher Peetz has made a total of 2 transactions in Alpine Immune Sciences Inc (ALPN) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Alpine Immune Sciences Inc is the sale of 1,900 shares on September 23, 2021, which brought Christopher Peetz around $19,323.
Insider Trading History of Christopher Peetz
- 1
Christopher Peetz Trading Performance
GuruFocus tracks the stock performance after each of Christopher Peetz's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher Peetz is 21.03%. GuruFocus also compares Christopher Peetz's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher Peetz within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher Peetz's insider trading performs compared to the benchmark.
Performance of Christopher Peetz
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.1 | | | | | |
| Relative Return to S&P 500(%) | -0.1 | | | | | |
Christopher Peetz Ownership Network
Christopher Peetz Owned Company Details
What does Mirum Pharmaceuticals Inc do?
Who are the key executives at Mirum Pharmaceuticals Inc?
Christopher Peetz is the director & President and CEO of Mirum Pharmaceuticals Inc. Other key executives at Mirum Pharmaceuticals Inc include SVP & Global Controller Jolanda Howe , director & 10 percent owner Patrick J Heron , and Chief Scientific Officer Pamela Vig .
Mirum Pharmaceuticals Inc (MIRM) Insider Trades Summary
Over the past 18 months, Christopher Peetz made 3 insider transaction in Mirum Pharmaceuticals Inc (MIRM) with a net sale of 16,720. Other recent insider transactions involving Mirum Pharmaceuticals Inc (MIRM) include a net sale of 11,012 shares made by Jolanda Howe , a net purchase of 162,308 shares made by Patrick J Heron , and a net sale of 34,606 shares made by Pamela Vig .
In summary, during the past 3 months, insiders sold 2,500 shares of Mirum Pharmaceuticals Inc (MIRM) in total and bought 345 shares, with a net sale of 2,155 shares. During the past 18 months, 108,350 shares of Mirum Pharmaceuticals Inc (MIRM) were sold and 176,308 shares were bought by its insiders, resulting in a net purchase of 67,958 shares.
Mirum Pharmaceuticals Inc (MIRM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mirum Pharmaceuticals Inc Insider Transactions
Christopher Peetz Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher Peetz. You might contact Christopher Peetz via mailing address: C/o Tobira Therapeutics, Inc., 701 Gateway Boulevard, #200, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
